FMS

Fresenius Medical Care AG & Co. KGaA

Healthcare · $11.9B market cap

Verdict

Share price

$22.25

close of Oct 3, 2026

Fair value

$19.10

Sticker Price

Payback Price

$7.64

buy price

Overpriced

FMS is Overpriced: at $22.25 it trades 16% above its fair value of $19.10. Its buy price (Payback Price) is $7.64, 66% below today's price. Business quality is limited: none of the 5 key numbers clears the 10% bar.

How we valued it

Free Cash Flow Growth. Free cash flow is growing faster than reported earnings, so we project free cash flow 10 years ahead instead.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth4.1% a year✗
Equity per share growth7.5% a year✗
Sales growth6.7% a year✗
Free cash flow growth9.0% a year✗
Return on invested capital4.1%✗

Follow FMS

Get notified when it reaches its buy price of $7.64. Free.

Create a free account

Superinvestors

2 of the investors we track hold FMS. Who we track

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co. KGaA specializes in comprehensive kidney dialysis treatment and associated services, operating across Germany, North America, and numerous international territories. Through an extensive network of outpatient clinics, it delivers essential dialysis therapy along with laboratory and diagnostic support. For home-based care, the company supplies necessary equipment, provides…

Medical - Care Facilities

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works